Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis
Open Access
Abstract
We retrospectively evaluated the usefulness of combined measurement of L-methyl-[11C]methionine (MET) and 3'-deoxy-3'-[18F]fluorothymidine (FLT) positron emission tomography (PET) in the differential diagnosis between recurrent gliomas and necrotic lesions. Twenty-one patients with high-grade glioma, previously treated with surgery and radiotherapy with chemotherapy and first radiological suspicion of recurrence were enrolled. The uptake was assessed by the maximum standardized uptake value (SUVmax) and lesion-to-normal tissue count density ratio (L/N ratio). Of the 21 lesions, 15 were diagnosed recurrent gliomas and six were necrotic lesions. The average SUVmax was not significantly different between recurrent gliomas and necrotic lesions on either MET-PET or FLT-PET. The average L/N ratio of recurrent gliomas (3.36 ± 1.06) was significantly higher than that of necrotic lesions (2.18 ± 0.66) on MET-PET (p < 0.01) and the average L/N ratio of recurrent gliomas (7.01 ± 2.26) was also significantly higher than that of necrotic lesions (4.60 ± 1.23) on FLT-PET (p < 0.01). ROC curve analysis showed that the areas under the curves were high but not different between MET- and FLT-PET. PET studies using MET and FLT are useful in the differentiation of recurrent glioma from treatment-induced necrotic lesion. However, there is no complementary information in the differentiation with simultaneous measurements of MET- and FLT-PET.Keywords
This publication has 38 references indexed in Scilit:
- Diagnostic Usefulness of 3’-Deoxy-3’-[18F]Fluorothymidine Positron Emission Tomography in Recurrent Brain TumorJournal of Computer Assisted Tomography, 2011
- 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed gliomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After RadiotherapyJournal of Nuclear Medicine, 2008
- Evaluation of Primary Brain Tumors With FLT-PET: Usefulness and LimitationsClinical Nuclear Medicine, 2006
- Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomasJournal of the Neurological Sciences, 2006
- Usefulness ofl-[methyl-11C] methionine—positron emission tomography as a biological monitoring tool in the treatment of gliomaJournal of Neurosurgery, 2005
- Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumorsJournal of Neurosurgery, 1999
- High L-Methyl-[11C]Methionine Uptake in Brain AbscessJournal of Computer Assisted Tomography, 1993
- Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Increased amounts of d-enantiomer dependent on alkaline concentration in the synthesis of l-[methyl-11C]methionineApplied Radiation and Isotopes, 1988